As 2025 concludes, QbD Pharma reflects on a year of dedication, innovation, and progress in global healthcare. Guided by our mission to deliver high-quality, accessible pharmaceutical solutions, we achieved key milestones across R&D, quality, and global collaboration.
2025 broughtsignificant R&D breakthroughs: we accelerated our drug pipeline, advanced key candidates through clinical stages, and strengthened independent R&D capabilities by completing key raw material master document filings, laying the groundwork for future commercialization.
Quality and compliance remained our priority—we optimized international quality management systems (ISO 13485, ISO 9001), refining processes to ensure our products meet the strictest global standards.
We also expanded our global footprint, engaging with international peers, participating in top industry forums, and aligning with global regulatory requirements to prepare for wider market expansion.
Grateful to our exceptional team, partners, and stakeholders for their support in 2025. Looking to 2026, we will build on these achievements to drive more impactful healthcare solutions worldwide.
